PyInvesting

Market research

EBO.AU EBOS Group Limited

AU AUD Healthcare

Latest close

Loading market data…

Test a moving-average rule with historical data.

Market cap
4B
P/E ratio
17.08
Analyst target
22.7325
Dividend yield
5.0%
Beta
0.15

Community

Investor discussion

1 comment

Admin profile picture
Admin

5 years, 5 months ago

EBOS Group Limited is currently in a long term uptrend where the price is trading 11.7% above its 200 day moving average.

From a valuation standpoint, the stock is 99.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.5.

EBOS Group Limited's total revenue rose by 6.3% to $5B since the same quarter in the previous year.

Its net income has increased by 13.7% to $93M since the same quarter in the previous year.

Finally, its free cash flow grew by 96.7% to $45M since the same quarter in the previous year.

Based on the above factors, EBOS Group Limited gets an overall score of 5/5.